1,732
Views
46
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964–2003 followed up to the end of 2006

, , , , , & show all
Pages 624-631 | Received 04 Dec 2009, Accepted 18 Dec 2009, Published online: 29 Apr 2010

References

  • Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99–166.
  • Engholm G, Ferlay J, Christensen N, Bray F, Klint Å, Ólafsdóttir E, . (2008). NORDCAN: Cancer incidence, mortality and prevalence in the Nordic countries, Version 3.3. http://www.ancr.nu. Association of Cancer Registries, Danish Cancer Society.
  • Colditz GA, Baer HJ, Tamimi RM. Breast cancer. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006. 995–1012.
  • Kroman N, Mouridsen HT. Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast 2003;12:516–21.
  • Phillips KA, Milne RL, West DW, Goodwin PJ, Giles GG, Chang ET, . Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 2009;18:1792–7.
  • Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, . EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931–91.
  • Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, . Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: Results of the EUROCARE-4 study. Lancet Oncol 2007; 8:773–83.
  • Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, . Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl. 1995;49:1–161.
  • Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, . Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003;106:416–22.
  • Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C. Associations of physician supplies with breast cancer stage at diagnosis and survival in Ontario, 1988 to 2006. Cancer 2009;115:3563–70.
  • Lawrence G, Wallis M, Allgood P, Nagtegaal ID, Warwick J, Cafferty FH, . Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. Breast Cancer Res Treat 2009;116:179–85.
  • Carlsen K, Høbye MT, Dalton SO, Tjønneland A. Social inequality and incidence of and survival from breast cancer in a population-based study in Denmark, 1994–2003. Eur J Cancer 2008;44:1996–2002.
  • Halmin M, Bellocco R, Lagerlund M, Karlsson P, Tejler G, Lambe M. Long-term inequalities in breast cancer survival – a ten year follow-up study of patients managed within a National Health Care System (Sweden). Acta Oncol 2008; 47:216–24.
  • Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: What have we learned? Radiol Clin North Am 2004;42: 793–806.
  • Møller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, . The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 2005;14:117–28.
  • Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: A systematic review. Lancet Oncol 2007;8: 1129–38.
  • Autier P, Boniol M, Héry C, Masuyer E, Ferlay J. Cancer survival statistics should be viewed with caution. Lancet Oncol 2007;8:1050–2.
  • Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol.
  • Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
  • Brenner H, Hakulinen T. Are patients diagnosed with breast cancer before age 50 years ever cured? J Clin Oncol 2004; 22:432–8.
  • Møller B, Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, . Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 2002;11(Suppl 1):S1–S96.
  • Hofvind S, Geller B, Vacek PM, Thoresen S, Skaane P. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 2007; 22:447–55.
  • Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 2002;9:153–8.
  • Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, . Relative survival of cancer patients–a comparison between Denmark and the other Nordic countries. Acta Oncol 1998;37:49–59.
  • Christensen LH, Engholm G, Ceberg J, Hein S, Perfekt R, Tange UB, . Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?–a population-based study. Eur J Cancer 2004;40: 1233–43.
  • Jensen AR, Garne JP, Storm HH, Engholm G, Möller T, Overgaard J. Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden? Acta Oncol 2004;43:719–26.
  • Christensen LH, Engholm G, Cortes R, Ceberg J, Tange U, Andersson M, . Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden. Eur J Cancer 2006;42:2773–80.
  • Blichert-Toft M, Christiansen P, Mouridsen HT. Danish Breast Cancer Cooperative Group-DBCG: History, organization, and status of scientific achievements at 30-year anniversary. Acta Oncol 2008;47:497–505.
  • Møller S, Jensen MB, Ejlertsen B, Bjerre KD, Larsen M, Hansen HB, . The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008;47:506–24.
  • Mouridsen HT, Bjerre KD, Christiansen P, Jensen MB, Møller S. Improvement of prognosis in breast cancer in Denmark 1977–2006, based on the nationwide reporting to the DBCG Registry. Acta Oncol 2008;47:525–36.
  • Dreyer L, Winther JF, Pukkala E, Andersen A. Avoidable cancers in the Nordic countries. Tobacco smoking. APMIS Suppl. 1997;76:9–47.
  • Dreyer L, Winther JF, Andersen A, Pukkala E. Avoidable cancers in the Nordic countries. Alcohol consumption. APMIS Suppl. 1997;76:48–67.
  • Tønnesen H, Nielsen PR, Lauritzen JB, Møller AM. Smoking and alcohol intervention before surgery: Evidence for best practice. Br J Anaesth 2009;102:297–306.
  • Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW. Comorbidity in older surgical cancer patients: Influence on patient care and outcome. Eur J Cancer 2007;43:2179–93.
  • Dalton SO, Düring M, Ross L, Carlsen K, Mortensen PB, Lynch J, . The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999. Br J Cancer 2006;95:653–9.
  • Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6:229–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.